India Serological Testing Market size was valued at USD 276.6 Million in 2024 and is expected to reach USD 798.2 Million by 2033, at a CAGR of 14.1% during the forecast period 2024 – 2033.
India Serological Testing Market: Overview
Serological tests are essential for understanding the prevalence of diseases within populations and for identifying individuals who have developed immunity against specific pathogens.
In India, the serological testing landscape has witnessed several notable trends in recent years. One prominent trend is the increasing adoption of rapid serological testing methods, driven by the need for quick and cost-effective diagnostic solutions, particularly in resource-constrained settings.
These rapid tests offer advantages such as shorter turnaround times and simplified procedures, making them particularly valuable for screening and surveillance efforts during infectious disease outbreaks.
Additionally, there’s a growing emphasis on multiplex serological assays capable of detecting multiple antibodies simultaneously, catering to the demand for comprehensive diagnostic insights and efficient testing workflows.
Moreover, advancements in technology and automation have led to the development of high-throughput serological testing platforms, enhancing laboratory efficiency and scalability. Overall, these trends reflect a shift towards more accessible, efficient, and comprehensive serological testing solutions tailored to meet the evolving healthcare needs of India’s diverse population.
By product, reagents & consumables segment held highest market share in 2023 and is expected to keep its dominance during the forecast period 2024-2033.
The trend in reagents and consumables is characterized by a shift towards personalized and specialized products, driven by advancements in biotechnology and molecular diagnostics. This includes the development of custom reagent kits tailored to specific research needs, alongside increased demand for sustainable and environmentally friendly consumables to reduce ecological impact in laboratory settings.
By application, malaria segment held highest market share in 2023 and is expected to keep its dominance during the forecast period 2024-2033. One notable trend in malaria is the increasing prevalence of drug-resistant strains, particularly in regions where the disease is endemic.
This poses significant challenges for treatment and control efforts, necessitating a focus on novel drug development, vector control strategies, and enhanced surveillance to combat the spread of resistant parasites.
In West India, a notable trend is the burgeoning adoption of telemedicine and digital health solutions, driven by factors such as urbanization, technological advancements, and the need for accessible healthcare. This trend is transforming healthcare delivery, enabling remote consultations, personalized care, and health monitoring, especially in densely populated urban centers.
Reliance Life Sciences is a medical biotechnology-led company engaged in research and development, manufacturing and marketing of differentiated medical products and services, used to treat patients primarily in intensive and critical care units in hospitals.
The major key players in India Serological Testing  market are PlasmaGen BioSciences Pvt. Ltd., Reliance Life Sciences, Biocon Limited, Intas Pharmaceuticals Ltd., Bharat Serums and Vaccines Limited, VIRCHOW BIOTECH, Fusion Healthcare, Kedrion S.p.A, Hemarus. and Others.
Report Scope
| Feature of the Report | Details |
| Market Size in 2024 | USD 276.6 Million |
| Projected Market Size in 2033 | USD 798.2 Million |
| Market Size in 2023 | USD 251.3 Million |
| CAGR Growth Rate | 14.1% CAGR |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Key Segment | By Product, Application and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Country Scope | India |
| Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
CMI has comprehensively analyzed India Serological Testing market. The driving forces, restraints, challenges, opportunities, and key trends have been explained in depth to depict an in-depth market scenario. Segment wise market size and market share during the forecast period are duly addressed to portray the probable picture of this India Serological Testing industry.
The competitive landscape includes key innovators, after market service providers, market giants, and niche players. These are studied and analyzed extensively concerning their strengths, weaknesses, and value addition prospects. In addition, this report covers key players profiling, market shares, mergers and acquisitions, consequent market fragmentation, new trends and dynamics in partnerships.
List of the prominent players in the India Serological Testing Market:
- Serological Research Institute
- Chembio Diagnostics Inc
- Cellex
- Randox Laboratories Ltd
- Abbott
- Bio-Rad Laboratories Inc.
- BD
- Thermo Fisher Scientific Inc.
- Ortho Clinical Diagnostics
- Quest Diagnostics Incorporated
- Abcam Plc
- Hoffmann-La Roche Ltd.
- ELITechGroup
- Teleflex Incorporated
- Grifols S.A.
- Global Scientific Company
- Beckman Coulter Inc.
- BIOMEDOMICS INC.
- Creative Diagnostics
- Others
The India Serological Testing Market is segmented as follows:
By Product
- Instruments
- Reagents & Consumables
By Application
- Hepatitis C
- Hepatitis B
- HIV
- Malaria
- Syphilis
- Blood Group Typing (BGT)
- Others